Thanks for that important question. I'm pleased that we've had time to come back to it. It's always a pleasure, MP Johns, to work with you.
Look, we have good news on the Moderna front; I just had a call with them this week. The relationship is an important one, and they have helped save many lives in Canada. This announcement that the Prime Minister made today I think is absolutely fantastic. We want to increase domestic supply and production, so that's exactly what we're going to do.
With respect to your question, it was exactly why I had reached out to Moderna. We want to make sure that we do have an ample supply. I will say that we have 20 million doses, with options for 15 million additional doses for both 2022 and 2023. Agreements are in place for a future supply of up to 95 million doses from 2022 to 2024. Those agreements are always on the latest formulations. As you will know, the “junior pediatric”, as we call it internally—there is a pediatric, but this is a junior—is essentially a portion of the vaccine that we have in possession now. As soon as Health Canada gives the approval, we're very happy that we will have the supply.